Multiple massive wildfires are raging in Los Angeles, blanketing the surrounding regions under a pungent haze caused by smoke ...

Fintel reports that on January 10, 2025, Needham upgraded their outlook for Collegium Pharmaceutical (NasdaqGS:COLL) from ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

The industry is set to make notable progress in cutting-edge areas such as CAR-T cell therapy, mRNA vaccines, and the ...

Fintel reports that on January 8, 2025, Citigroup initiated coverage of West Pharmaceutical Services (NYSE:WST) with a Buy ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avadel Pharmaceuticals (AVDL – Research Report) ...

About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

Based on the one-year price targets offered by 10 analysts, the average target price for Avadel Pharmaceuticals PLC (NASDAQ:AVDL) is $23.30 with a high estimate of $27.00 and a low estimate of $20.00.

Whales with a lot of money to spend have taken a noticeably bullish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 10 trades.

Healthcare has been one of Jim Cramer’s favorite topics lately. The tail end of the year has pushed a portion of the sector, ...

The widespread use of pharmaceuticals in America is introducing even more toxic “forever chemicals” into the environment ...

According to market observers, Senores Pharmaceuticals IPO GMP is signaling 73% listing gain for the lucky allottees ...